Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Assessment and diagnosis of the non-Alzheimer dementias 

Assessment and diagnosis of the non-Alzheimer dementias
Chapter:
Assessment and diagnosis of the non-Alzheimer dementias
Author(s):

Chiadi U. Onyike

DOI:
10.1093/med/9780198701590.003.0127
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 24 January 2021

Non-Alzheimer dementias are commonly distinguished from Alzheimer disease by younger age at onset (midlife or earlier), positive family history, and presentations characterized by non-amnesic cognitive deficits, psychiatric states (such as depression, compulsions, paranoia, and hallucinations) and motor dysfunctions (like parkinsonism, ataxia, and apraxia). Missed diagnosis is a common problem, with the conditions being mistaken for psychiatric or movement disorder. Timely diagnosis depends on methodical examinations that characterize the chronology and tempo of key symptoms, family history, and neurological features, and brain images that reveal telltale patterns of atrophy or dysfunction. Genetic, blood, and CSF assays, and EEG are indicated where family history is positive or illness progression rapid. As non-Alzheimer dementias pose many clinical and psychosocial problems, optimal care requires a multidisciplinary team, empowered carers, and leverage of community resources. The latest discoveries in neuroimaging, particularly amyloid-PET, tau-PET, and clinical genetics, promise improvements in diagnostics and new therapeutic opportunities.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.